BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10980270)

  • 1. Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 2000 Sep; 404(1-2):121-32. PubMed ID: 10980270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
    Fornal CA; Metzler CW; Gallegos RA; Veasey SC; McCreary AC; Jacobs BL
    J Pharmacol Exp Ther; 1996 Aug; 278(2):752-62. PubMed ID: 8768728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
    Gartside SE; Umbers V; Sharp T
    Psychopharmacology (Berl); 1997 Apr; 130(3):261-8. PubMed ID: 9151361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
    Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
    J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
    Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
    Arborelius L; Wallsten C; Ahlenius S; Svensson TH
    Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE; Haddjeri N; Debonnel G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.
    Eltayb A; Svensson TH; Ahlenius S
    Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
    Bosker FJ; Folgering JH; Gladkevich AV; Schmidt A; van der Hart MC; Sprouse J; den Boer JA; Westerink BH; Cremers TI
    J Neurochem; 2009 Mar; 108(5):1126-35. PubMed ID: 19166502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.